companyName


Bicycle Therapeutics plc Website Screenshot

http://www.bicycletherapeutics.com

Bicycle Therapeutics plc Company Intro

Bicycle Therapeutics plc, a clinical-stage biopharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics. Its lead product candidate is BT1718, a bicycle toxin conjugate (BTC), which is in Phase I/IIa clinical trials targeting tumors that express Membrane Type 1 matrix metalloprotease. The company's oncology product candidates also comprise BT5528, a BTC that is in a Phase I/IIa clinical trial targeting EphA2; BT8009, which is in preclinical studies targeting Nectin-4; and CD137, an immune cell co-stimulatory molecule that is in preclinical stage. In addition, it is developing THR-149, a plasma kallikrein inhibitor that completed Phase I clinical trials for the treatment of diabetic macular edema. Further, the company collaborates with biopharmaceutical companies and organizations to develop programs in therapeutic areas, such as anti-infective, cardiovascular, ophthalmology, and respiratory indications. Bicycle Therapeutics plc has a clinical trial and license agreement with the Cancer Research Technology Limited and CRUK; research collaboration agreements with AstraZeneca, Sanofi, Oxurion, and the Dementia Discovery Fund; and discovery collaboration and license agreement with Genentech for the discovery and development of Bicycle peptides for multiple immuno-oncology targets. The company was incorporated in 2009 and is headquartered in Cambridge, the United Kingdom.

Industry

Healthcare

Bicycle Therapeutics plc Headquaters

Babraham Research Campus
Cambridge,CB22 3AT
United Kingdom


Bicycle Therapeutics plc Share price

14 Sep 2022 08:44 GMT

$25.00

0.02 (0.08 %)


Bicycle Therapeutics plc Market cap

$724.69 M


WMC RANKING

2022

Bicycle Therapeutics plc # 180

Biotechnology

Latest Bicycle Therapeutics plc News

News 05 Dec 2022

Update on Short Interest for Bicycle Therapeutics plc ...

The short interest in Bicycle Therapeutics plc dramatically declined in November (NASDAQ: BCYC). As of November 15, 2,550,000 shares were shorted,...

News 05 Dec 2022

There's a new sense of excitement surrounding Bicycle ...

Bicycle Therapeutics plc (NASDAQ: BCYC) closed the day trading at $31.73 up 9.83% from the previous closing price of $28.89. In other words, the price has...

News 05 Dec 2022

Update on Short Interest for Bicycle Therapeutics plc ...

The short interest in Bicycle Therapeutics plc dramatically declined in November (NASDAQ: BCYC). As of November 15, 2,550,000 shares were shorted,...


WMC Market Score


WMC Market to Revenue Score


Bicycle Therapeutics plc Market Financials


Revenue, Expenses, Profit


Company Currency Revenue Expense Profit Market Cap WMC Sector Score
Bicycle Therapeutics plc USD $11,069 $67,410 $-55,877 $7,247M 180
Regeneron Pharmaceuticals, Inc. USD $9,197,600 $3,997,800 $4,003,800 $754,300B 1
Vertex Pharmaceuticals Incorporated USD $6,414,881 $2,617,257 $2,762,032 $713,610B 2
Alexion Pharmaceuticals, Inc. USD $6,261,601 $2,747,200 $681,800 $ 3
Incyte Corporation USD $2,702,913 $2,048,306 $478,480 $150,520B 4

Market Analytics


Company Search vs Top 4 Industry Competitors



Total Bicycle Therapeutics plc Social Followers vs Top 4 Industry Competitors



Bicycle Therapeutics plc Post vs Top 4 Industry Competitors




Bicycle Therapeutics plc Digital Footprint By Size vs Top 4 Industry Competitors



Bicycle Therapeutics plc Digital Footprint By Change Rate vs Top 4 Industry Competitors



Bicycle Therapeutics plc WMC Market Score Calculations


Details Revenue Total Social Followers Total Social Posts Search Volume Digital Footprint Size Digital change (New Pages) WMC Market Score
Bicycle Therapeutics plc 0.12 0 0 0 0 0 0.03
Regeneron Pharmaceuticals, Inc. 100 25.50 16.15 22 0 0 28.52
Vertex Pharmaceuticals Incorporated 69.75 35.68 8.95 33 0 0 34.78
Alexion Pharmaceuticals, Inc. 68.08 100 100 22 0 0 100
Incyte Corporation 29.39 5.03 0.04 100 0 0 47.37

Book a demo

Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.

* required fields


You'll learn how to:

  • 1. Automatically monitor your entire digital landscape including competitors
  • 2. View all new industry activity in real time
  • 3. Monitor your position in your industry
  • 4. Enrich your reports and strategy
  • 5. Empower your teams with knowledge

Our platform is loved & trusted by avariety
of world-leading brands

  • unilever
  • wavesight
  • acca
  • abeerdeen
  • UK2
  • umbo
  • rb
Industries